This study was terminated in Bulgaria, in Estonia, in Germany, .... It is testing Lu AF11167 for schizophrenia.
SchizophreniaDrugOver 18 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether Lu AF11167 may be useful for adults experiencing schizophrenia.
What would participation involve?
Participants may receive Lu AF11167, attend study visits with the research team. The registry lists locations in Bulgaria, in Estonia, and in Germany.
Who is it mainly for?
This study appears to be mainly for adults with schizophrenia.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Bulgaria · 10 sites
Mental Health Center Prof. Dr. Ivan Temkov EOOD (BG0001)
Burgas
Site status: Not listed — confirm with the team
MHAT Dr. Hristo Stambolski (BG0007)
Kazanlak
Site status: Not listed — confirm with the team
First Department for men with acute mental diseases-NPH Sv. Ivan Rilski (BG0010)
Novi Iskar
Site status: Not listed — confirm with the team
UMHAT Dr.Georgi Stranski EAD (BG0006)
Pleven
Site status: Not listed — confirm with the team
State Psychiatric Hospital - Sevlievo (BG0009)
Sevlievo
Site status: Not listed — confirm with the team
Medical Center INTERMEDICA (BG0003)
Sofia
Site status: Not listed — confirm with the team
DCC Mladost-M (BG0004)
Varna
Site status: Not listed — confirm with the team
Med Centre Medical plus (BG0008)
Varna
Site status: Not listed — confirm with the team
DCC Mladost-M Varna OOD (BG0005)
Varna
Site status: Not listed — confirm with the team
Mental Health Center-Vratsa EOOD (BG0002)
Vratsa
Site status: Not listed — confirm with the team
Estonia · 2 sites
Marienthali Kliinik (EE0001)
Tallinn
Site status: Not listed — confirm with the team
OU Jaanson & Laane (EE0002)
Tartu
Site status: Not listed — confirm with the team
Germany · 1 site
Office of Dr.Kirsten Hahn MD (DE0002)
Berlin
Site status: Not listed — confirm with the team
Hungary · 4 sites
Semmelweis Egyetem Neurologiai Klinika-Semmelweis University (HU0005)
Budapest
Site status: Not listed — confirm with the team
Bugat Pal Hospital (HU0008)
Gyöngyös
Site status: Not listed — confirm with the team
Dr Mathe es Tarsa Bt (HU0001)
Kalocsa
Site status: Not listed — confirm with the team
Javorszky Odon Hospital (HU0004)
Vác
Site status: Not listed — confirm with the team
Latvia · 3 sites
Hospital Gintermuiza (LV0001)
Jelgava
Site status: Not listed — confirm with the team
Riga Centre Of Psychiatry And Addiction Disorders (LV0002)
Riga
Site status: Not listed — confirm with the team
Sigulda Hospital Outpatient Clinic (LV0006)
Sigulda
Site status: Not listed — confirm with the team
Poland · 1 site
Syntonia Sp. z o.o. (PL0002)
Pruszcz Gdański
Site status: Not listed — confirm with the team
Ukraine · 9 sites
Si Inpn Namsu (Ua0003)
Kharkiv
Site status: Not listed — confirm with the team
Si Inpn Namsu (Ua0008)
Kharkiv
Site status: Not listed — confirm with the team
Kherson Regional Psychiatric Hospital (UA0009)
Kherson
Site status: Not listed — confirm with the team
Kiev Regional Specialized Psycho-Narcological Medical Care (UA0005)
Kiev
Site status: Not listed — confirm with the team
Regional Clinical Psychiatry Hospital of Kirovograd Regional Council, Donetsk National Medical University (UA0004)
Kropyvnytskyi
Site status: Not listed — confirm with the team
"Kyiv Railway Clinical Hospital ¿1 of Branch ""Health Center"" of the Public joint stock company ""Ukrainian Railway"", psychoneurological department" (UA0007)
Kyiv
Site status: Not listed — confirm with the team
Odessa Regional Medical Centre of Mental Health (UA0006)
Odesa
Site status: Not listed — confirm with the team
Ukrainian Medical Stomatological Academy (UA0001)
Poltava
Site status: Not listed — confirm with the team
Vinnitsa National Medical University (UA0002)
Vinnytsia
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Lu AF11167. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.
Who might this study be for?
This study may concern people with schizophrenia; age range: Over 18 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by H. Lundbeck A/S, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
